| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | NTLA | Common Stock | 67.6K | Jan 13, 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | NTLA | Stock Option (right to buy) | Jan 13, 2025 | Common Stock | 40K | $27.33 | Direct | F2 | ||||||
| holding | NTLA | Stock Option (right to buy) | Jan 13, 2025 | Common Stock | 20K | $18.30 | Direct | F3 | ||||||
| holding | NTLA | Stock Option (right to buy) | Jan 13, 2025 | Common Stock | 10.6K | $14.58 | Direct | F4 | ||||||
| holding | NTLA | Stock Option (right to buy) | Jan 13, 2025 | Common Stock | 30K | $13.40 | Direct | F5 | ||||||
| holding | NTLA | Stock Option (right to buy) | Jan 13, 2025 | Common Stock | 20.6K | $57.71 | Direct | F6 | ||||||
| holding | NTLA | Stock Option (right to buy) | Jan 13, 2025 | Common Stock | 3.5K | $134.06 | Direct | F7 | ||||||
| holding | NTLA | Stock Option (right to buy) | Jan 13, 2025 | Common Stock | 25K | $40.75 | Direct | F8 | ||||||
| holding | NTLA | Stock Option (right to buy) | Jan 13, 2025 | Common Stock | 31.8K | $32.66 | Direct | F9 |
| Id | Content |
|---|---|
| F1 | Includes (i) a grant of 16,080 restricted stock units, (ii) a grant of 7,500 restricted stock units, (iii) a grant of 3,440 restricted stock units, (iiii) a grant of 400 restricted stock units, (v) a grant of 20,839 restricted stock units, (vi) a grant of 17,668 restricted stock units, and (vii) a grant of 22,045 restricted stock units, each representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. |
| F2 | This option was granted on October 2, 2017 with respect to 40,000 shares of Common Stock, with 25% vesting on September 18, 2018 and the remaining 75% vesting in thirty-six (36) substantially equal monthly installments thereafter. |
| F3 | This option was granted on December 12, 2017 with respect to 20,000 shares of Common Stock, with 25% vesting on December 12, 2018 and the remaining 75% vesting in thirty-six (36) substantially equal monthly installments thereafter. |
| F4 | This option was granted on December 18, 2018 with respect to 30,000 shares of Common Stock, with 25% vesting on December 18, 2019 and the remaining 75% vesting in thirty-six (36) substantially equal monthly installments thereafter. |
| F5 | This option was granted on March 2, 2020 with respect to 30,000 shares of Common Stock, with 25% vesting on January 1, 2021 and the remaining 75% vesting in thirty-six (36) substantially equal monthly installments thereafter. |
| F6 | This option was granted on March 3, 2021 with respect to 20,600 shares of Common Stock, with 25% vesting on January 1, 2022 and the remaining 75% vesting in thirty-six (36) substantially equal monthly installments thereafter. |
| F7 | This option was granted on October 1, 2021 with respect to 3,500 shares of Common Stock, with 25% vesting on October 1, 2022 and the remaining 75% vesting in thirty-six (36) substantially equal monthly installments thereafter. |
| F8 | This option was granted on March 1, 2023 with respect to 24,965 shares of Common Stock, with 33% vesting on January 1, 2024 and the remaining 67% vesting in twenty-four (24) substantially equal monthly installments thereafter. |
| F9 | This option was granted on March 1, 2024 with respect to 31,816 shares of Common Stock, with 33% vesting on January 1, 2025 and the remaining 67% vesting in twenty-four (24) substantially equal monthly installments thereafter. |
Exhibit 24.1 - Power of Attorney.